Thyroid dysfunction - Chronic Myeloid Leukemia - CML
TKIs can induce thyroid dysfunction
ARTICLES
Thyroid autoimmunity and hypothyroidism are associated with deep molecular response in patients with chronic myeloid leukemia on tyrosine kinase inhibitors
July 20, 2021, PubMed
Imatinib Therapy in Chronic Myelogenous Leukemia and Thyroid Function Tests
July 1, 2014, 2014, NCBI
Tyrosine Kinase Inhibitors Induced Thyroid Dysfunction: A Review of Its Incidence, Pathophysiology, Clinical Relevance, and Treatment
October 27, 2013, NCBI
Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia
2010, PubMed
Thyroid autoimmunity and hypothyroidism are associated with deep molecular response in patients with chronic myeloid leukemia on tyrosine kinase inhibitors
July 20, 2021, PubMed
Imatinib Therapy in Chronic Myelogenous Leukemia and Thyroid Function Tests
July 1, 2014, 2014, NCBI
Tyrosine Kinase Inhibitors Induced Thyroid Dysfunction: A Review of Its Incidence, Pathophysiology, Clinical Relevance, and Treatment
October 27, 2013, NCBI
Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia
2010, PubMed
